Adding GIP to GLP-1 agonism improved average weight loss from roughly 15% to roughly 22% in Phase 3 trials, in part because GIP receptor activation enhances insulin sensitivity in adipose tissue through pathways that GLP-1 alone cannot access
We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in reports we have filed or will file with the Commission, including our most recently filed Annual Report on Form 10-K, our most recently filed Quarterly Report on Form 10-Q, and any of our subsequent filings with the Commission
Consider the human evidence base for BPC-157 in full
It's direct evidence that mirtazapine engages the endocannabinoid system
Low dead space needles: Reduce medication waste at the needle hub
If there are any issues with the shipment, they will send another one promptly